oxprenolol

Public-database records for oxprenolol (CAS 6452-73-9), reproduced here for independent cross-checking.

Safety classification and hazard statements

Regulatory listings

How this substance is indexed

Documented uses

• Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
• Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
• Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
• Drugs used to cause dilation of the blood vessels.

Names this substance appears under

Oxprenolol hydrochloride; 6452-73-9; Oxprenolol HCl; Slow-Trasicor; Ba-39089; DTXSID5021093; F4XSI7SNIU; 2-Propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, hydrochloride; BA-39,089; 1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride; DTXCID001093; 2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, hydrochloride; Apsolox; Laracor; Paritane; Trasicor ret

Computed molecular descriptors

Database abstract

oxprenolol · CAS 6452-73-9 · C15H24ClNO3. UNII F4XSI7SNIU.

Source: PubChem / Wikidata; the batch COA governs where values differ.